GlassScriptPhysician profile
Alan Benjamin Swearingen
NPI 1245588672
$11,754.32
in general payments reported to CMS, 2019-2025
48 companies · $1,363 in 2025
The $1,363 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,864 · 2020: $2,332 · 2021: $1,673 · 2022: $1,764 · 2023: $1,226 · 2024: $1,532 · 2025: $1,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,120.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,874.45 | 2019-2024 | Senza |
| Relievant Medsystems, INC. | $1,306.22 | 2021-2023 | Intracept |
| Medtronic USA, INC. | $953.64 | 2019-2020 | |
| Boston Scientific Corporation | $919.13 | 2019-2025 | Intracept Rf Probe, Intracept, Wavewriter Alpha Prime 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $646.10 | 2019-2024 | Relistor |
| Globus Medical, INC. | $630.72 | 2025 | Senza, Vyrsa V1 |
| Scilex Pharmaceuticals INC. | $625.90 | 2019-2024 | Ztlido |
| Collegium Pharmaceutical, INC. | $564.53 | 2019-2025 | Belbuca, Xtampza |
| Vertos Medical, INC. | $496.88 | 2020-2023 | Mild Device Kit |
| Horizon Therapeutics Plc | $236.03 | 2019-2021 | |
| Abbott Laboratories | $234.99 | 2019-2025 | Proclaim |
| Flowonix Medical Incorporated | $207.68 | 2019 | |
| Azurity Pharmaceuticals, INC. | $206.91 | 2023-2025 | Horizant, Horizant |
| Averitas Pharma INC. | $189.62 | 2023-2025 | Qutenza |
| Si-Bone, INC. | $128.97 | 2019 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Swearingen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.